Van Gaal, L F <br/><br/>
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Jan 2010 
 - 26-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2009.01090.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Appetite Depressants--therapeutic use<br/>Blood Pressure--drug effects<br/>Cardiovascular Diseases--drug therapy<br/>Cyclobutanes--therapeutic use<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Obesity--complications<br/>Weight Loss--drug effects